Literature DB >> 20451612

Linear and conformation specific antibodies in aged beagles after prolonged vaccination with aggregated Abeta.

Vitaly Vasilevko1, Viorela Pop, Hyun Jin Kim, Tommy Saing, Charles C Glabe, Saskia Milton, Edward G Barrett, Carl W Cotman, David H Cribbs, Elizabeth Head.   

Abstract

Previously we showed that anti-Abeta peptide immunotherapy significantly attenuated Alzheimer's-like amyloid deposition in the central nervous system of aged canines. In this report we have characterized the changes that occurred in the humoral immune response over 2.4years in canines immunized repeatedly with aggregated Abeta(1-42) (AN1792) formulated in alum adjuvant. We observed a rapid and robust induction of anti-Abeta antibody titers, which were associated with an anti-inflammatory T helper type 2 (Th2) response. The initial antibody response was against dominant linear epitope at the N-terminus region of the Abeta(1-42) peptide, which is identical to the one in humans and vervet monkeys. After multiple immunizations the antibody response drifted toward the elevation of antibodies that recognized conformational epitopes of assembled forms of Abeta and other types of amyloid. Our findings indicate that prolonged immunization results in distinctive temporal changes in antibody profiles, which may be important for other experimental and clinical settings.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20451612      PMCID: PMC2910127          DOI: 10.1016/j.nbd.2010.04.014

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  58 in total

Review 1.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

Review 2.  Landmark discrimination learning in the dog: effects of age, an antioxidant fortified food, and cognitive strategy.

Authors:  Norton W Milgram; E Head; B Muggenburg; D Holowachuk; H Murphey; J Estrada; C J Ikeda-Douglas; S C Zicker; C W Cotman
Journal:  Neurosci Biobehav Rev       Date:  2002-10       Impact factor: 8.989

Review 3.  Use of novel adjuvants and delivery systems to improve the humoral and cellular immune response to malaria vaccine candidate antigens.

Authors:  D M Gordon
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

Review 4.  Lymphokine control of in vivo immunoglobulin isotype selection.

Authors:  F D Finkelman; J Holmes; I M Katona; J F Urban; M P Beckmann; L S Park; K A Schooley; R L Coffman; T R Mosmann; W E Paul
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

5.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

6.  Vaccination of Alzheimer's model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages.

Authors:  Ayodeji A Asuni; Allal Boutajangout; Henrieta Scholtzova; Elin Knudsen; Yong Sheng Li; David Quartermain; Blas Frangione; Thomas Wisniewski; Einar M Sigurdsson
Journal:  Eur J Neurosci       Date:  2006-11       Impact factor: 3.386

7.  Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes.

Authors:  Magdalena Anguiano; Richard J Nowak; Peter T Lansbury
Journal:  Biochemistry       Date:  2002-09-24       Impact factor: 3.162

8.  The dog genome: survey sequencing and comparative analysis.

Authors:  Ewen F Kirkness; Vineet Bafna; Aaron L Halpern; Samuel Levy; Karin Remington; Douglas B Rusch; Arthur L Delcher; Mihai Pop; Wei Wang; Claire M Fraser; J Craig Venter
Journal:  Science       Date:  2003-09-26       Impact factor: 47.728

9.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

10.  Measurement of IgG, IgM and IgA concentrations in canine serum, saliva, tears and bile.

Authors:  A J German; E J Hall; M J Day
Journal:  Vet Immunol Immunopathol       Date:  1998-07-08       Impact factor: 2.046

View more
  6 in total

1.  Design and Optimization of Anti-amyloid Domain Antibodies Specific for β-Amyloid and Islet Amyloid Polypeptide.

Authors:  Christine C Lee; Mark C Julian; Kathryn E Tiller; Fanling Meng; Sarah E DuConge; Rehana Akter; Daniel P Raleigh; Peter M Tessier
Journal:  J Biol Chem       Date:  2015-11-24       Impact factor: 5.157

2.  Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-terminal immunodominant epitope of the amyloid β peptide.

Authors:  Remy Robert; Marie-Paule Lefranc; Anahit Ghochikyan; Michael G Agadjanyan; David H Cribbs; William E Van Nostrand; Kim L Wark; Olan Dolezal
Journal:  Mol Immunol       Date:  2010 Nov-Dec       Impact factor: 4.407

3.  Positron emission tomography imaging of fibrillar parenchymal and vascular amyloid-β in TgCRND8 mice.

Authors:  Daniel McLean; Michael J Cooke; Ricardo Albay; Charles Glabe; Molly S Shoichet
Journal:  ACS Chem Neurosci       Date:  2013-03-19       Impact factor: 4.418

4.  A cyclic undecamer peptide mimics a turn in folded Alzheimer amyloid β and elicits antibodies against oligomeric and fibrillar amyloid and plaques.

Authors:  Peter Hoogerhout; Willem Kamphuis; Humphrey F Brugghe; Jacqueline A Sluijs; Hans A M Timmermans; Janny Westdijk; Gijsbert Zomer; Claire J P Boog; Elly M Hol; Germie P J M van den Dobbelsteen
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

5.  Structural differences of amyloid-β fibrils revealed by antibodies from phage display.

Authors:  Patrick Droste; André Frenzel; Miriam Steinwand; Thibaut Pelat; Philippe Thullier; Michael Hust; Hilal Lashuel; Stefan Dübel
Journal:  BMC Biotechnol       Date:  2015-06-18       Impact factor: 2.563

Review 6.  Aptamers Selected for Recognizing Amyloid β-Protein-A Case for Cautious Optimism.

Authors:  Farid Rahimi
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.